CL Stock Analysis — Colgate-Palmolive
Sector: Consumer Staples
AI Verdict
Colgate-Palmolive trades at 22x next year's earnings while analysts expect nearly 48% EPS growth—cheap for the growth you're getting if its brand moat keeps competitors at bay, but any stumble could see the premium evaporate fast.
Competitive Moat
Colgate-Palmolive dominates oral care globally through entrenched distribution in emerging markets and high brand loyalty, making it hard for new entrants to dislodge shelf space. Its scale in supply chain and marketing creates cost advantages that smaller competitors can't easily replicate.
Summary
Colgate-Palmolive is notable for a projected 47.8% jump in earnings next year despite a flat year for the stock.
Where It Stands
Shares are down -5.88% over the past year with an RSI of 50.4 (neutral), and the stock trades at 22.0x next year's earnings versus the sector median of 20x.
Key Metrics
- RSI: 50.4 — Neutral
- Trailing P/E: 32.6x
- Forward P/E: 22.0x
- PEG Ratio: 0.71
- Earnings Growth: +0.5%
- Revenue Growth: +0.0%
- Market Cap: $68.7B
- Dividend Yield: 0.03%
- 1-Year Return: -5.88%
- 52-Week High: $99.33
- 52-Week Low: $74.55
Analyst Consensus
19 Buy · 10 Hold · 1 Sell (30 analysts)
Bull Case
Forward EPS growth of 47.8% paired with a 22.0x forward P/E means you're paying a fair multiple for unusually strong earnings momentum in a defensive sector.
Bear Case
If the P/E falls from 22.0x to the sector median of 20x, the stock would lose about 9% even if earnings meet expectations.
Catalyst to Watch
Watch for quarterly earnings surprises—if the company delivers on the 47.8% EPS growth, the premium multiple is more likely to hold.